Former employees of Procter & Gamble, Merck & Co. and Bristol Myers Squibb have all found new homes in the pharma industry in this week's People column.
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including appointments at PhRMA, BIO, Shire, Eli Lilly and DPT Laboratories.
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including appointments at Morphotek and Qualitest and resignations at Sigma-Aldrich and GenVec.
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including appointments at Roche, AVI BioPharma, Amgen and Delcath Systems.
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including a retirement at Pfizer, a new CEO at B-MS and appointments at Mylan, Archimedes and Kinex.
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including appointments at Noven, Inspire, AP Pharma and Tarsa Therapeutics.
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including Genzyme strengthening its manufacturing team and Carl Icahn’s representative joining Adventrex’s board.
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including Genzyme strengthening its quality team and appointments at ISPE and Biogen Idec.
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including Novartis’ former CEO joining Amylin’s board and an appointment at OctoPlus.
US company Mylan Laboratories has reached a final agreement with
Bristol-Myers Squibb, which resolves all disputes between the
companies related to buspirone.
